Targeted therapy is a type of cancer treatment that works by targeting specific molecules or pathways that are involved in the growth and spread of cancer cells. There are several targeted therapy medicines that may be used to treat ovarian cancer, including:

• PARP inhibitors: PARP inhibitors are a type of targeted therapy that work by blocking enzymes that help repair damaged DNA in cancer cells. These drugs are often used in patients with advanced ovarian cancer and a BRCA gene mutation, as they are more likely to respond to this type of treatment. Some examples of PARP inhibitors include olaparib, rucaparib, and niraparib.
• Bevacizumab: Bevacizumab is a targeted therapy drug that works by blocking the growth of new blood vessels in the tumor. This can help to slow down the growth and spread of the cancer cells. Bevacizumab is often used in combination with chemotherapy to treat advanced ovarian cancer.
• Atezolizumab: Atezolizumab is a targeted therapy drug that works by blocking a protein called PD-L1, which can help cancer cells evade the immune system. This drug is often used in combination with chemotherapy to treat advanced ovarian cancer.
• Cediranib: Cediranib is a targeted therapy drug that works by blocking the growth of new blood vessels in the tumor. This can help to slow down the growth and spread of the cancer cells. Cediranib is often used in combination with chemotherapy to treat advanced ovarian cancer.

Immunotherapy is a type of cancer treatment that works by stimulating the patient’s immune system to recognize and attack cancer cells. While immunotherapy is still being studied for ovarian cancer, there are several immunotherapy medicines that may be used in certain cases. These include:

• Pembrolizumab: Pembrolizumab is an immunotherapy drug that works by blocking a protein called PD-1, which can help cancer cells evade the immune system. This drug is often used in patients with advanced ovarian cancer who have already received other treatments, such as chemotherapy.
• Nivolumab: Nivolumab is another immunotherapy drug that works by blocking PD-1. This drug may be used in patients with advanced ovarian cancer who have already received other treatments, such as chemotherapy.
• Atezolizumab: Atezolizumab is an immunotherapy drug that works by blocking a protein called PD-L1, which can help cancer cells evade the immune system. This drug is often used in combination with chemotherapy to treat advanced ovarian cancer.
• Ipilimumab: Ipilimumab is an immunotherapy drug that works by activating the patient’s immune system to attack cancer cells. This drug may be used in certain cases of ovarian cancer, such as those that are refractory to other treatments.

Some types of ovarian cancer are sensitive to hormones such as estrogen or progesterone. Hormone therapy may be used to block the effects of these hormones on the cancer cells. Hormone therapy is usually used for recurrent ovarian cancer, rather than as a primary treatment.